00002-1717 Inluriyo - CanMED: NDC

Product NDC:

00002-1717

Brand Name:

Inluriyo

Generic Name:

Imlunestrant

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: IMLUNESTRANT

Strength: 200.0

Unit: mg/1

Packages:

Code: 00002-1717-28

Description: 28 TABLET, FILM COATED in 1 BOTTLE (0002-1717-28)

Effective Date: Oct. 16, 2025

Discontinued:

Code: 00002-1717-56

Description: 56 TABLET, FILM COATED in 1 BOTTLE (0002-1717-56)

Effective Date: Oct. 15, 2025

Discontinued:

Code: 00002-1717-61

Description: 56 TABLET, FILM COATED in 1 BOTTLE (0002-1717-61)

Effective Date: Nov. 13, 2025

Discontinued:

SEER*Rx Category:

Hormonal Therapy

Major Class:

Estrogen Receptor Antagonist

Minor Class:

ER⍺

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox